Topics

SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research

12:06 EDT 2 May 2019 | Xconomy

Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the Vancouver, BC-based drug developer from Seattle Genetics (NASDAQ: SGEN), where he was vice president of clinical development. In other moves, Zymeworks appointed Mark Hollywood to serve as senior vice president, technical and manufacturing operations, and Bruce Hart […]

Original Article: SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research

NEXT ARTICLE

More From BioPortfolio on "SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research"

Quick Search

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...